Suresh K. Kalangi, N.K. Swarnakar, R.Sathyavathi, S. Jain, D.Narayana Rao and Rdanna Pallu, Synthesis, characterization and bio distribution studies of Quantum Dot-Celecoxib conjugates in mouse paw edema model. Oxid Med Cell Longev, 2017.
Suresh K Kalangi, Dayakar A, Satyavathi, Radheshyam Mourya and Narayna Rao D, Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the anti-leishmanial efficacy of meltefosine. Exp Parasitol. (2016) Nov; 170:184-192.
Kalangi, Suresh K.; Sathyavathi, R.; Rao, D. Narayana; Pallu, Reddanna, Bio-imaging of 5Fluorouracil Conjugated to CdTe Quantum Dots in MCF-7 Breast Cancer Cells Journal of Bionanoscience Vol. 6, 1–6, 2012.
Jagadeesh, M., M. Lavanya, Suresh K. Kalangi, Y. Sarala, C. Ramachandraiah, and A. Varada Reddy. "Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper (II), nickel (II) and palladium (II) complexes." Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 135 (2015): 180-184.
Jagadeesh, Suresh K Kalangi, L. SivaramaKrishna, A. Varada Reddy, Halo-substituted thiosemicarbazones and their Copper(II), Nickel(II) complexes: Detailed spectroscopic characterization and study of Antitumor Activity against HepG2 human hepatoblastoma cells Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 118 (2014) 552–556.
Gokara, Mahesh, Tirupathi Malavath, Suresh Kumar Kalangi, Pallu Reddana, and Rajagopal Subramanyam. "Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications." Journal of Biomolecular Structure and Dynamics 32, no. 8 (2014): 1290-1302.
P. Aparoy, K Kumar Reddy, Suresh K Kalangi, T Chandramohan Reddy and P Reddanna., Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors, Bioorg Med Chem Lett. 20 (3): 1013-8 (2010).
Chandramohan Reddy, Tamatam; Aparoy, Polamarasetty; Kishore Babu, Neela; Anil Kumar, Kotha; Suresh K Kalangi, Reddanna, Pallu. Kinetics and Docking Studies of a COX-2 Inhibitor Isolated from Terminalia bellerica fruits. Protein and Peptide Letters, Volume 17, Number 10, October 2010, pp. 1251-1257.